DCM
VTAE

DAFNA Capital Management’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

DAFNA Capital Management’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-715,988
Closed -$15M – 82
2016
Q3 		$15M Buy
715,988
+55,800
+8% +$643K 10.43% 1
2016
Q2 		$7.12M Sell
660,188
-127,185
-16% -$1.09M 5.65% 3
2016
Q1 		$5.22M Buy
787,373
+594,149
+307% +$5.4M 4.5% 4
2015
Q4 		$3.5M Buy
193,224
+122,339
+173% +$1.68M 3.12% 8
2015
Q3 		$780K Buy
+70,885
New +$753K 0.77% 36

DAFNA Capital Management's VTAE Position: Q4 2016 in Review

DAFNA Capital Management sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 715,988 shares — an estimated $15M sold.

DAFNA Capital Management first reported a position in VTAE in Q3 2015 and held it in 5 quarters. The position peaked at $15M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • DAFNA Capital Management reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • DAFNA Capital Management sold 715,988 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $15M.
  • DAFNA Capital Management first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2015 and held it in 5 quarters.
  • DAFNA Capital Management's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $15M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on DAFNA Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.